Viking Therapeutics (Warrant)

$4.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.22 (-4.24%) Today
-$0.25 (-5.01%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can watch VKTXW and buy or sell other stocks, options, and ETFs commission-free!

About VKTXW

Viking Therapeutics, Inc. Warrants, also called Viking Therapeutics (Warrant), is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. The firm's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. The listed name for VKTXW is Viking Therapeutics, Inc. Warrants.

CEO
Brian Lian, PhD, MBA
Employees
—
Headquarters
San Diego, California
Founded
2012
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.52K
High Today
$5.35
Low Today
$5.09
Open Price
$5.35
Volume
603.00
52 Week High
$8.52
52 Week Low
$1.81

You May Also Like

APXT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure